234 related articles for article (PubMed ID: 23345025)
1. Presence of anti-proteinase 3 antineutrophil cytoplasmic antibodies (anti-PR3 ANCA) as serologic markers in inflammatory bowel disease.
Arias-Loste MT; Bonilla G; Moraleja I; Mahler M; Mieses MA; Castro B; Rivero M; Crespo J; López-Hoyos M
Clin Rev Allergy Immunol; 2013 Aug; 45(1):109-16. PubMed ID: 23345025
[TBL] [Abstract][Full Text] [Related]
2. PR3-ANCA: a promising biomarker for ulcerative colitis with extensive disease.
Mahler M; Bogdanos DP; Pavlidis P; Fritzler MJ; Csernok E; Damoiseaux J; Bentow C; Shums Z; Forbes A; Norman GL
Clin Chim Acta; 2013 Sep; 424():267-73. PubMed ID: 23806819
[TBL] [Abstract][Full Text] [Related]
3. The diagnostic role and clinical association of serum proteinase 3 anti-neutrophil cytoplasmic antibodies in Chinese patients with inflammatory bowel disease.
Xu Y; Xu F; Li W; Li M; Dong S; Zhang Y; Norman GL; Zhao Q; Liu L
Scand J Gastroenterol; 2020 Jul; 55(7):806-813. PubMed ID: 32568566
[No Abstract] [Full Text] [Related]
4. Role of Serum Proteinase 3 Antineutrophil Cytoplasmic Antibodies in the Diagnosis, Evaluation of Disease Severity, and Clinical Course of Ulcerative Colitis.
Imakiire S; Takedatsu H; Mitsuyama K; Sakisaka H; Tsuruta K; Morita M; Kuno N; Abe K; Funakoshi S; Ishibashi H; Yoshioka S; Torimura T; Hirai F
Gut Liver; 2022 Jan; 16(1):92-100. PubMed ID: 35027509
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic role and clinical correlates of anti-Saccharomyces cerevisiae antibodies (ASCA) and anti-neutrophil cytoplasmic antibodies (p-ANCA) in Italian patients with inflammatory bowel diseases.
Saibeni S; Folli C; de Franchis R; Borsi G; Vecchi M
Dig Liver Dis; 2003 Dec; 35(12):862-8. PubMed ID: 14703881
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic accuracy of serum proteinase 3 antineutrophil cytoplasmic antibodies in children with ulcerative colitis.
Mizuochi T; Arai K; Kudo T; Nambu R; Tajiri H; Aomatsu T; Abe N; Kakiuchi T; Hashimoto K; Sogo T; Takahashi M; Etani Y; Takaki Y; Konishi KI; Ishihara J; Obara H; Kakuma T; Kurei S; Yamashita Y; Mitsuyama K
J Gastroenterol Hepatol; 2021 Jun; 36(6):1538-1544. PubMed ID: 33047817
[TBL] [Abstract][Full Text] [Related]
7. PR3-ANCA and panel diagnostics in pediatric inflammatory bowel disease to distinguish ulcerative colitis from Crohn's disease.
Horn MP; Peter AM; Righini Grunder F; Leichtle AB; Spalinger J; Schibli S; Sokollik C
PLoS One; 2018; 13(12):e0208974. PubMed ID: 30557305
[TBL] [Abstract][Full Text] [Related]
8. Anti-Proteinase 3 Antibodies as a Biomarker for Ulcerative Colitis and Primary Sclerosing Cholangitis in Children.
Laass MW; Ziesmann J; de Laffolie J; Röber N; Conrad K
J Pediatr Gastroenterol Nutr; 2022 Apr; 74(4):463-470. PubMed ID: 35703948
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of serologic disease markers in a population-based cohort of patients with ulcerative colitis and Crohn's disease.
Sandborn WJ; Loftus EV; Colombel JF; Fleming KA; Seibold F; Homburger HA; Sendid B; Chapman RW; Tremaine WJ; Kaul DK; Wallace J; Harmsen WS; Zinsmeister AR; Targan SR
Inflamm Bowel Dis; 2001 Aug; 7(3):192-201. PubMed ID: 11515844
[TBL] [Abstract][Full Text] [Related]
10. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype.
Zholudev A; Zurakowski D; Young W; Leichtner A; Bousvaros A
Am J Gastroenterol; 2004 Nov; 99(11):2235-41. PubMed ID: 15555007
[TBL] [Abstract][Full Text] [Related]
11. Antineutrophil cytoplasmic antibodies, anti-Saccharomyces cerevisiae antibodies, and specific IgE to food allergens in children with inflammatory bowel diseases.
Bartůnková J; Kolárová I; Sedivá A; Hölzelová E
Clin Immunol; 2002 Feb; 102(2):162-8. PubMed ID: 11846458
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic utility, disease activity, and disease phenotype correlation of serum ASCA, pANCA, and PR3-ANCA in pediatric inflammatory bowel disease.
Kim JM; Choi YM; Jung SA; Yang HR
J Pediatr (Rio J); 2024; 100(2):204-211. PubMed ID: 38012956
[TBL] [Abstract][Full Text] [Related]
13. Anti-proteinase 3 antineutrophil cytoplasmic antibody reflects disease activity and predicts the response to steroid therapy in ulcerative colitis.
Aoyama Y; Inaba T; Takahashi S; Yasuhara H; Hiraoka S; Morimoto T; Colvin HS; Wato M; Ando M; Nakamura S; Mizobuchi K; Okada H
BMC Gastroenterol; 2021 Aug; 21(1):325. PubMed ID: 34425765
[TBL] [Abstract][Full Text] [Related]
14. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role.
Quinton JF; Sendid B; Reumaux D; Duthilleul P; Cortot A; Grandbastien B; Charrier G; Targan SR; Colombel JF; Poulain D
Gut; 1998 Jun; 42(6):788-91. PubMed ID: 9691915
[TBL] [Abstract][Full Text] [Related]
15. PR3-ANCA: a promising biomarker in primary sclerosing cholangitis (PSC).
Stinton LM; Bentow C; Mahler M; Norman GL; Eksteen B; Mason AL; Kaplan GG; Lindkvist B; Hirschfield GM; Milkiewicz P; Cheung A; Janssen HL; Fritzler MJ
PLoS One; 2014; 9(11):e112877. PubMed ID: 25397578
[TBL] [Abstract][Full Text] [Related]
16. Anti-neutrophil cytoplasmic antibodies in chronic inflammatory bowel disease. Prevalence and diagnostic role.
Hertervig E; Wieslander J; Johansson C; Wiik A; Nilsson A
Scand J Gastroenterol; 1995 Jul; 30(7):693-8. PubMed ID: 7481534
[TBL] [Abstract][Full Text] [Related]
17. Antibodies to Escherichia coli outer membrane porin C in the absence of anti-Saccharomyces cerevisiae antibodies and anti-neutrophil cytoplasmic antibodies are an unreliable marker of Crohn disease and ulcerative colitis.
Davis MK; Andres JM; Jolley CD; Novak DA; Haafiz AB; González-Peralta RP
J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):409-13. PubMed ID: 18030205
[TBL] [Abstract][Full Text] [Related]
18. [p-ANCA and ASCA antibodies in the differential diagnosis between ulcerative rectocolitis and Crohn's disease].
Lecis P; Germanà B; Papa N; Bertiato G; Doglioni C; Galliani E; Biedo FC
Recenti Prog Med; 2002 May; 93(5):308-13. PubMed ID: 12050913
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic role and clinical association of ASCA and ANCA in Brazilian patients with inflammatory bowel disease.
Nisihara RM; de Carvalho WB; Utiyama SR; Amarante H; Baptista ML
Dig Dis Sci; 2010 Aug; 55(8):2309-15. PubMed ID: 19826949
[TBL] [Abstract][Full Text] [Related]
20. Update on Anti-Saccharomyces cerevisiae antibodies, anti-nuclear associated anti-neutrophil antibodies and antibodies to exocrine pancreas detected by indirect immunofluorescence as biomarkers in chronic inflammatory bowel diseases: results of a multicenter study.
Desplat-Jégo S; Johanet C; Escande A; Goetz J; Fabien N; Olsson N; Ballot E; Sarles J; Baudon JJ; Grimaud JC; Veyrac M; Chamouard P; Humbel RL
World J Gastroenterol; 2007 Apr; 13(16):2312-8. PubMed ID: 17511029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]